Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
OP Labs reports a turning point for crypto monetization as exchange-owned stack chains made a near-$500 million oncha...
The bitcoin’s drop toward $72,000 intensified as U.S.-Iran tensions resurfaced, prompting a risk-off move across cryp...
A leadership moment at Wendy’s puts the iconic burger under a microscope, with the U.S. president pledging unwavering...
Brent crude traded around $97.5 per barrel at 9 a.m. ET on May 28, 2026, keeping the focus on the current price 2026....
April inflation rose to 3.8% year over year, the hottest in nearly three years, as gas and groceries push costs highe...
As tech’s power demand surges, data centers are becoming a bigger profit driver for utilities, prompting fresh debate...
Hedge fund veteran Dan Loeb argues tech is the most attractive sector in the current rally, warning against draconian...
DTCC unveils plans to connect its tokenized securities platform to the Stellar blockchain by mid-2027, signaling a ma...
SpaceX's planned NASDAQ debut includes two pivotal admissions that could influence investor risk assessments: Starshi...
Schwab’s US Large-Cap ETF (SCHX) remains a cost-efficient way to diversify across the core U.S. market. As volatility...
A wave of AI demand and energy-cost pressures are reviving interest in crypto operators who pivot to AI compute. The ...